Frozen Tissue Samples Market
Number of pages: 100 | Report Format: PDF | Published date: December 01, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market size value in 2021 |
US$ 104.02 million |
|
Revenue forecast in 2030 |
US$ 311.98 million |
|
Growth Rate |
CAGR of 12.98% from 2022 to 2030 |
|
Base year for estimation |
2021 |
|
Forecast period |
2022-2030 |
|
Segments covered |
by product type, application, end user, and region |
|
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The global frozen tissue samples market was pegged at US$ 104.02 million in 2021 and is expected to witness a CAGR of 12.98 % during the forecast period.
Market Fundamentals
The frozen section or tissue samples technique is a useful procedure for quickly preparing slides from tissue for microscopic interpretation. Numerous clinical and research settings employ frozen tissue technique for gathering information on molecular and genetic level. Fundamental use of this technique is in rapid diagnosis of mass during surgical procedures. Moreover, the technique is also used to manufacture culturing cells to obtain primary frozen tissues.
[7589793]
Market Dynamic
Rising incidences of tumor disease is the primary driver propelling the market. This increase in prevalence is also increasing research and development procedures for disease diagnosis, treatments, and structural analysis. Moreover, frozen tissue samples are best choice in analysis methods such as NGS (Next generation sequencing), mass spectroscopy, western blotting, and real time polymerase chain reaction. Frozen tissue samples are the ideal choice for DNA and RNA sequencing. The samples are also beneficial in immunohistochemistry since the proteins are still in their original state. Despite many influencing factors pathological contamination, loss of tissue integrity from subsequent thawing and freezing, and maintaining ideal freezing conditions during transportation are factors which can limit the market growth.
Market Ecosystem
The global frozen tissue samples market has been analyzed from four perspectives: by product type, application, end user, and region
Frozen Tissue Samples Market by Product Type
[24325325]
The global frozen tissue samples market according to product type is grouped into frozen normal tissue samples, frozen tumor tissue samples, fresh frozen tissue samples, formalin-fixed paraffin-embedded tissues, frozen diseased tissue samples. Frozen tumor tissue samples segment has the majority of the shares. This is attributed to increasing trends of molecular level diagnosis. Further, in case if patient has become resistant to certain treatment, a proper diagnosis at genomic level can be obtained by tumor tissue samples. Moreover, the segment will increase at high CAGR in the forecast period due to rising prevalence of cancer.
Frozen Tissue Samples Market by Application
Based on application, the market is divided into three segments cancer research, disease diagnosis, and research and therapeutics. Cancer research segment dominated the market in 2021. Due to its improved DNA preservation capabilities, frozen tissue is the chosen material to identify gene mutation in cancer studies. For studying gene expression, frozen (FF) tissue is highly preferred. In addition to this, frozen tissues are reliable source in researching cell structure and morphology, disease states, intra- and intercellular communication, or related subjects.
Frozen Tissue Samples Market by End user
Based on end user, the global frozen tissue samples market is divided into hospital & clinics, diagnostic centers, forensic laboratories, academic & research centers, and pharmaceutical & biotechnology companies. Academic & research centers have dominated the market. Rising research & development activities is the major factor influencing the market growth. Further freezing tissues can ease examination procedures, experimental research techniques, and in drug development activities.
Frozen Tissue Samples Market by Region
Regionally, the global frozen tissue samples market has been segmented into North America, Europe, Asia Pacific, and the rest of the world. North America has majority of market shares. This is attributed to increasing cancer causing death. Furthermore, many manufacturers have brought technological advances which is anticipated to increase the market. Increasing research and development activities in the region is another factor contributing to the growth of the market. European market is classified as increasing trends of molecular and genetic level disease diagnosis. Further, adoption of frozen tissue sample collection technique is increasing in forensic sciences, pathological labs, and diagnostic centers in the region.
Competitive Landscape
Some of the prominent players operating in the frozen tissue samples market are
The frozen section or tissue samples technique is a useful procedure for quickly preparing slides from tissue for microscopic interpretation.
Rising incidences of tumor disease is the primary driver propelling the market. This increase in prevalence is also increasing research and development procedures for disease diagnosis, treatments, and structural analysis. Moreover, frozen tissue samples are best choice in analysis methods such as NGS (Next generation sequencing), mass spectroscopy, western blotting, and real time polymerase chain reaction. Frozen tissue samples are the ideal choice for DNA and RNA sequencing. The samples are also beneficial in immunohistochemistry since the proteins are still in their original state.
Some of the prominent players operating in the frozen tissue samples market are ProteoGenex, Inc., Biochain Institute Inc., OriGene Technologies, Inc., ZenBio, Inc., Geneticist Inc., AMS Biotechnology (Europe) Limited, Leica Biosystems, US Biolab Corporation, Inc. ReproCELL Inc., and Bay Biosciences LLC among others.
Despite of many influencing factors pathological contamination, loss of tissue integrity from subsequent thawing and freezing, and maintaining ideal freezing conditions during transportation are some factors which can limit the market potential.
The global frozen tissue samples market was pegged at US$ 104.02 million in 2021 and is expected to witness a CAGR of 12.98 % during the forecast period.
*Insights on financial performance is subject to availability of information in public domain